CIRM Funded Clinical Trials

A Phase I, Pilot Study of Human Embryonic Stem Cell-Derived Cardiomyocytes in PaTients with ChrOnic Ischemic Left VentRicular Dysfunction (HECTOR)

Disease Area: 
Investigator:
CIRM Grant:
Award Value:
$6,987,507
Trial Sponsor:
Stanford University
Trial Stage: 
Phase 1
Trial Status: 
Not yet recruiting
Targeted Enrollment:
18
ClinicalTrials.gov ID: